Brief: Oryzon Receives 'Decision To Grant' Communications From Canada And Israel For Vafidemstat Patent Applications
July 14 (Reuters) - Oryzon Genomics SA ORY.MC: RECEIVES 'DECISION TO GRANT' COMMUNICATIONS FROM CANADA AND ISRAEL FOR VAFIDEMSTAT PATENT APPLICATIONS ONCE FORMALLY GRANTED, CANADIAN AND ISRAELI PATENTS TO REMAIN IN FORCE UNTIL AT LEAST 2038 Source text: https://tinyurl.com/msntsyc6 nFWN3N303J Further company coverage: ORY.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28